October 14th, 2011
Podcast 134: How (and why) surveillance in Barrett’s esophagus should change
Audio Player
Podcast: Play in new window | Download
Subscribe: RSS
Barrett’s esophagus no longer carries the promise of esophageal cancer that it seemed to, but it bears watching, especially in the first year after the finding, when most cancers are found.
The first author of this week’s New England Journal of Medicine study tracking the progression of a finding of Barrett’s over a median 5-year period offers some advice on how to proceed.
Links:
Categories: Audio, Barrett's esophagus, esophageal adenocarcinoma, Uncategorized
Tags: adenocarcinoma, Barrett's esophagus, biopsy, endoscopy, esophageal cancer, esophageal dysplasia, Frederik Hvid-Jensen, surveillance
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Subscribe to Clinical Conversations via Email
Archives
-
Recent Posts
- Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2
- Podcast 301: Monkeypox — what to look for, how to treat
- Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
- Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
- Podcast 297: Forget about all that vitamin D testing!!
- Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?
- Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?
- Podcast 294: PD-1 blockade in locally advanced rectal cancer
- Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
- Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway?
-
Tag Cloud
- 2009 H1N1 acute coronary syndromes aspirin asthma blood pressure breast cancer cancer risk cardiovascular disease Cardiovascular risk COPD coronary heart disease dabigatran dementia depression diabetes Diabetes type 2 diet Elderly Emergency medicine epidemiology falls FDA glucose guidelines H1N1 Heart failure hypertension influenza pain Patient care patients pregnancy Prostate cancer prostate screening proton pump inhibitors PSA Quality of care risk Rivaroxaban screening smoking stents stroke vaccination warfarin